{"meta":{"query_hash":"3b60410619f4","filters":{"venue":"Therapeutic Advances in Ophthalmology"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/3b60410619f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Ophthalmology"},"results":[{"id":"W3080271774","doi":"10.1177/2515841420950846","title":"Biomarkers for central serous chorioretinopathy","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Serous fluid; Macular degeneration; Macular edema; Ophthalmology; Retinal pigment epithelium; Vascularity; Disease; Retinal detachment; Fluorescein angiography; Pathology; Retinal","score_opus":0.06164635095844938,"score_gpt":0.4212999241756651,"score_spread":0.3596535732172157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080271774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000745163,0.9944635,0.000058262962,0.00008438034,0.00057490205,0.002526023,0.00012220159,0.000042595468,0.0020536173],"genre_scores_gemma":[0.0009969324,0.99675304,0.00067200133,0.000094147574,0.0002568155,0.000610534,0.0003328492,0.00010314334,0.00018052745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774486,0.00015904088,0.0006207668,0.00067892176,0.00015264386,0.0006437699],"domain_scores_gemma":[0.9987897,0.00030525718,0.00028443403,0.00036036057,0.000033907338,0.00022629868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008047064,0.0005435271,0.0022270537,0.00015459277,0.000045071356,0.00000972836,0.00022676626,0.0003190371,0.00015677775],"category_scores_gemma":[0.000050708346,0.00040889505,0.00066120253,0.00030631406,0.00016516309,0.000057171837,0.000048790353,0.00028237829,0.00004983046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006278961,0.00023033426,0.0006598838,0.010313028,0.00048903265,0.002029673,0.000025517218,3.7876444e-7,1.747893e-7,0.0002630612,0.000008173685,0.9853529],"study_design_scores_gemma":[0.0013455454,0.0013276231,0.00024957335,0.0031709936,0.0018403825,0.004247698,0.000024057028,0.000010068091,4.854727e-7,0.001159236,0.9862989,0.00032541002],"about_ca_topic_score_codex":0.0000051192023,"about_ca_topic_score_gemma":3.619118e-7,"teacher_disagreement_score":0.98629075,"about_ca_system_score_codex":0.00026865953,"about_ca_system_score_gemma":0.00031171893,"threshold_uncertainty_score":0.99983627},"labels":[],"label_agreement":null},{"id":"W4410267798","doi":"10.1177/25158414251321730","title":"Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Ophthalmology","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Aflibercept; Retinopathy of prematurity; Medicine; Ophthalmology; Pediatrics; Optometry; Surgery; Gestational age; Pregnancy; Bevacizumab; Biology","score_opus":0.012573917164528867,"score_gpt":0.3047335192538736,"score_spread":0.2921596020893447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410267798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96337026,0.016473582,0.000003197751,0.00439731,0.011802046,0.0034786519,0.00015626084,0.000056230736,0.0002624332],"genre_scores_gemma":[0.9877872,0.0029256055,0.0008780745,0.0002476069,0.0067055956,0.0003668468,0.0003841433,0.00009354246,0.0006114108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956759,0.0011164811,0.00056593015,0.0012043832,0.000787277,0.0006499893],"domain_scores_gemma":[0.99374753,0.0044972473,0.0005867097,0.0008984845,0.00018271062,0.00008733348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046696083,0.0010043196,0.0025028114,0.00033446203,0.0002250545,0.00007782597,0.0005055675,0.0006552897,0.000083770006],"category_scores_gemma":[0.00022473391,0.00063553825,0.00010793818,0.00049921084,0.0010858023,0.00024683666,0.00040229972,0.0014198706,0.000001505022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04503058,0.0037553275,0.6946416,0.002047651,0.0035628104,0.0032650363,0.20072,0.000035764042,0.00040177561,0.0000019706335,0.043078825,0.0034586962],"study_design_scores_gemma":[0.09138031,0.046209015,0.41353422,0.030205127,0.0073583536,0.0008452786,0.3332032,0.00017011054,0.003720869,0.0006311786,0.068137676,0.004604674],"about_ca_topic_score_codex":0.0009572469,"about_ca_topic_score_gemma":0.0059446823,"teacher_disagreement_score":0.28110734,"about_ca_system_score_codex":0.0007148577,"about_ca_system_score_gemma":0.00015425691,"threshold_uncertainty_score":0.9996096},"labels":[],"label_agreement":null}]}